Sun Pharma Says SEBI Ordered Forensic Audit Of Financial Statements
The Sun Pharmaceutical Industries Ltd. logo sits on a sign on pharmaceutical and medical supply storage racks inside the Nippon Yusen K.K. pharma distribution center at the Port of Antwerp in Antwerp, Belgium. (Photographer: Jasper Juinen/Bloomberg)

Sun Pharma Says SEBI Ordered Forensic Audit Of Financial Statements

Bookmark

Drug major Sun Pharmaceutical Industries Ltd. on Thursday said a forensic audit has been ordered by markets regulator Securities and Exchange Board of India with regard to its financial statements for three financial years between 2015-16 and 2017-18.

In a regulatory filing, Sun Pharma said, "A forensic audit has been ordered by SEBI with respect to the financial statements of Sun Pharmaceutical Industries Ltd. for the financial years ending March 31, 2016, March 31, 2017 and March 31, 2018".

The said forensic audit is currently going on, it added.

Sun Pharma, however, did not provide any specific details on the reasons for SEBI to order the forensic audit.

A forensic audit is an examination and evaluation of a firm's or individual's financial records to derive evidence that can be used in a court of law or legal proceeding.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.